| Basics |
Medtronic plc
Medtronic PLC is a medical technology company. It is primarily manufactures and sells device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$129.94B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.58 | 0.87%
|
| Avg Daily Range (30 D): |
$0.84 | 0.87%
|
| Avg Daily Range (90 D): |
$0.82 | 0.87%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.18M |
| Avg Daily Volume (30 D): |
5.57M |
| Avg Daily Volume (90 D): |
5.44M |
| Trade Size |
| Avg Trade Size (Sh.): |
143 |
| Avg Trade Size (Sh.) (30 D): |
66 |
| Avg Trade Size (Sh.) (90 D): |
68 |
| Institutional Trades |
| Total Inst.Trades: |
110,493 |
| Avg Inst. Trade: |
$4.76M |
| Avg Inst. Trade (30 D): |
$12.38M |
| Avg Inst. Trade (90 D): |
$12.47M |
| Avg Inst. Trade Volume: |
.07M |
| Avg Inst. Trades (Per Day): |
19 |
| Market Closing Trades |
| Avg Closing Trade: |
$46.47M |
| Avg Closing Trade (30 D): |
$117.13M |
| Avg Closing Trade (90 D): |
$107.74M |
| Avg Closing Volume: |
565.7K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$3.72
|
$1.07
|
$.81
|
|
Diluted EPS
|
$3.7
|
$1.07
|
$.81
|
|
Revenue
|
$ 34.76B
|
$ 8.96B
|
$ 8.58B
|
|
Gross Profit
|
$ 22.77B
|
$ 5.9B
|
$ 5.58B
|
|
Net Income / Loss
|
$ 4.79B
|
$ 1.38B
|
$ 1.05B
|
|
Operating Income / Loss
|
$ 6.21B
|
$ 1.69B
|
$ 1.45B
|
|
Cost of Revenue
|
$ 11.99B
|
$ 3.06B
|
$ 3B
|
|
Net Cash Flow
|
$ -112M
|
$ 9M
|
$ -945M
|
|
PE Ratio
|
27.39
|
|
|
|
|
|
